Reimagining the EconomyCOVID-19Make Me Smart DailyRace and Economy

Loading...

0:00
0% played
Stories Tagged as

FDA

COVID-19

FDA issues alert about accuracy of Abbott rapid COVID-19 test

by David Brancaccio , Nova Safo and Alex Schroeder
May 15, 2020
The concern is that it could be returning false negative results.
For now, negative results from the Abbott test should be confirmed with another more sensitive test.
Win McNamee/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
Econ Extra Credit with David Brancaccio

In the COVID-19 economy, unintended consequences play a part in policymaking

by David Brancaccio and Erika Soderstrom
Apr 23, 2020
A rise in domestic violence, a decline in car accidents and more.
FDA deregulation of COVID-19 antibody tests has led to a false sense of security for some, an unintended consequence of the move.
Al Bello/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE

The search for tastier grocery store tomatoes is closing in

by Sabri Ben-Achour
Nov 22, 2019
While identifying lost flavor genes and bringing them back has been tricky, some scientists are determined.
The flavor of tomatoes is hard to track, unlike disease.
Scott Olson/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE

Energy drinks may cause serious heart problems, study shows

by Renata Sago
May 30, 2019
A combination of ingredients may cause potentially life-threatening electrical malfunctions in the heart.
Jack Taylor/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE

New gene therapy drug expected to hit market with head-spinning price tag

by Kimberly Adams
May 22, 2019
Industry analysts expect the price for the single-treatment therapy to be anywhere from $1.5 million to $5 million.
Swiss pharmaceutical giant Novartis' Basel headquarters.
SEBASTIEN BOZON/AFP/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Government shutdown 2019

Tech IPOs were set for a comeback, then the government shut down

by Molly Wood
Jan 18, 2019
Is the tech IPO resurgence at risk?
Companies like Uber that have filed for IPOs are stalled while the SEC lawyers and accountants who work on IPOs are shut down along with the government.
Adam Berry/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Menthol ban would undo years of marketing to African Americans

by Erika Beras
Nov 16, 2018
After World War II, tobacco companies found blacks slightly preferred menthol more than whites; decades of marketing followed.
 Menthol cigarettes are seen for sale on a shelf at a Quick Stop store on March 30, 2010 in Miami, Florida.
Joe Raedle/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

You’ve got questions. We help you answer them.

Support nonprofit, independent journalism that makes you smarter.

Invest in Marketplace

FDA may seek to regulate menthol and e-cigarettes

by Tracey Samuelson
Nov 12, 2018
Regulatory changes would face a process that could take years and face litigation.
 Menthol cigarettes are seen for sale on a shelf at a Quick Stop store on March 30, 2010 in Miami, Florida. 
Joe Raedle/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

FDA warns e-cigarette manufacturers about teen use

by Justin Ho
Sep 12, 2018
They warn the usage of e-cigarettes by teens has reached an epidemic proportion.
Dan Kitwood/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Here's why there's a shortage of EpiPens

by Dan Gorenstein
Aug 23, 2018
The Food and Drug Administration is trying to help mitigate the shortage of EpiPens, those auto-injecting devices used to treat allergic reactions to things like peanuts and bee stings. It’s extended by four months the expiration date for some EpiPen…
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE